Impact of CYP2C19*17 on the Pharmacokinetics of Proguanil and Clopidogrel
NCT01456546
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
31
Enrollment
OTHER
Sponsor class
Conditions
CYP2C19 Genotypes
Interventions
DRUG:
Proguanil
DRUG:
Clopidogrel
Sponsor
University of Southern Denmark